Cielo is emerging as a dedicated partner in hepatology clinical trials, with a focus on MASH and obesity assessments.
Our approach integrates advanced imaging techniques with insightful analysis, providing critical data to support the development and evaluation of novel therapies.
Our Capabilities:
-Advanced Imaging Techniques:Cielo specializes in multi-modal image acquisition, including MRI-PDFF (Magnetic Resonance Imaging-Proton Density Fat Fraction), MRE (Magnetic Resonance Elastography), CT (Computed Tomography), and DXA (Dual-energy X-ray Absorptiometry). These techniques are pivotal in accurately assessing liver fat content, stiffness, and body composition, offering non-invasive markers of treatment efficacy.
- Comprehensive Obesity Assessments: Beyond MASH, our expertise extends to detailed obesity assessments, crucial for understanding the metabolic impact of therapeutic interventions. This includes the quantification of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), intermuscular adipose tissue (IMAT), and organ/muscle volumes, providing a holistic view of metabolic health.
- Collaborative Expertise: We are building collaborations with key opinion leaders (KOLs) and radiologists specializing in MASH. This collaborative network enhances our capability to offer comprehensive imaging solutions that align with the latest scientific advancements and regulatory expectations.
- Quality and Precision: Emphasizing quality control and precision, we are committed to implementing robust site certification and training. This ensures that the data generated is of the highest quality, providing reliable evidence to support clinical decision-making.
Why Partner with Cielo for MASH and Obesity Trials?
- Tailored Imaging Solutions: At Cielo, we understand that each trial has unique requirements. We are dedicated to providing tailored imaging solutions that meet the specific needs of your study, from early-phase evidence of efficacy to detailed assessments of treatment impact.
- Emerging Technology Integration: Leveraging the latest in imaging technology and analysis methodologies, Cielo is at the forefront of integrating innovative solutions to enhance trial outcomes and accelerate the path to treatment discovery.
- Commitment to Advancement: Our goal is to contribute significantly to the field of hepatology by providing cutting-edge imaging capabilities that can transform the evaluation and understanding of MASH and obesity. With Cielo, you gain a partner that is dedicated to excellence and innovation in clinical trial imaging.
Driving Hepatology Research Forward:
Cielo is poised to make a meaningful impact in hepatology research, particularly in the areas of MASH and obesity. Our commitment to leveraging multi-modal imaging techniques and our emerging expertise positions us as a promising partner in advancing clinical trials and ultimately improving patient outcomes in these critical areas of need.
Liver elastography USG +MRI
Much More
At Cielo, we offer specialized imaging expertise across diverse therapeutic areas including neurology, rheumatology, and gastrointestinal (GI) disorders, employing advanced DICOM imaging technology to support a wide range of clinical trials.
Our dedicated team is adept at leveraging cutting-edge imaging techniques to deliver precise and reliable data, crucial for the development of novel therapeutics. From the intricate assessment of neurological conditions to the detailed evaluation of rheumatic diseases and the complex imaging requirements of GI disorders, Cielo provides tailored imaging solutions that enhance trial accuracy and efficiency.
Our commitment to innovation and quality ensures that we meet the unique challenges of each therapeutic area, facilitating the successful execution of clinical trials and advancing medical research.